AK7-10469-11449
4 vaccinations
1 coded response
47 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 550 / MN
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-15
Registered in v-safe
-
2021-01-15
Dose 1 — Moderna
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-29
- 2021-02-05
-
2021-02-12
Dose 2 — Moderna
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint painsAdult check-in
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-05-14
-
2021-08-17
Survey response — 6 months, dose 2MedDRA: Cough, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activitiesFree text: Congestion, cough, fever/ChillsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-12-10
Dose 3 — Moderna
- 2021-12-10
-
2021-12-11
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-16
- 2021-12-17
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-01-14
- 2022-01-21
- 2022-03-11
- 2022-06-10
-
2022-12-02
Dose 4 — Pfizer-BioNTech
- 2022-12-10
- 2022-12-10
- 2022-12-16
- 2022-12-23
- 2022-12-30
- 2023-01-06
- 2023-01-13
- 2023-03-03
- 2023-06-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-15 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-12-10 | Moderna | No |
| 4 | 2022-12-02 | Pfizer-BioNTech | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: Congestion, cough, fever/Chills
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | Pyrexia | ✓ | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release